How does ibogaine interrupt opioid withdrawal?

In observational studies, ibogaine eased opioid withdrawal within days [1][2]. In lab tests and in healthy volunteers, it does not act like an opioid [3][4]. The body turns it into a second drug, noribogaine, that lasts for days [1][3]. Lab work points to several targets at once, such as the kappa and NMDA receptors [5][6].

How does ibogaine stop opioid withdrawal?

Research points to ibogaine easing opioid withdrawal by several routes at once [5][7]. Switching on the mu receptor, the way opioid drugs work, is not one of them [4]. A 2019 research paper calls the full mechanism behind its effect on drug-seeking unresolved [5]. The main leads are noribogaine, the kappa receptor and a few targets outside the opioid system [1][6][7].

In a St Kitts treatment series, doctors scored withdrawal signs lower 36 hours after a single dose [1]. People treated in Mexico rated their own withdrawal at less than half its starting score about three days later [8]. In a Dutch hospital study, most patients did not go back to morphine in the 24 hours after their dose [2].

Former patients asked about it later describe the same relief. Eight in ten said ibogaine ended or sharply cut their withdrawal [9].

Withdrawal itself has a well-described cause. Opioids quiet the brain cells that release noradrenaline, a chemical that keeps the body alert [10]. With repeated use, those cells speed up to make up for it [10]. When the opioid stops, nothing holds them back [10]. The flood of noradrenaline brings the jitters, anxiety, muscle cramps and diarrhea of withdrawal [10].

Picture a foot pressing harder on the accelerator to fight a brake. Release the brake and the car lurches forward.

Standard medicines meet this in two ways. Methadone and buprenorphine are opioids themselves, and they take the place of the drug a person stopped [11][12]. Clonidine is not an opioid [13]. It calms the noradrenaline surge and eases some signs of withdrawal [13].

People weighing ibogaine often ask how relief can arrive without an opioid to replace the one they stopped. The sections below take each candidate in turn. The wider evidence base is covered in Ibogaine: What the Evidence Shows in 2026.

What receptors does ibogaine work on?

Ibogaine attaches to many targets in the brain, including opioid, NMDA and nicotinic receptors [5]. It also binds the pumps that mop up serotonin and dopamine [5].

A typical drug works like a dimmer on one circuit. Ibogaine reaches across the whole fuse board.

What each binding does is still being worked out [5]. The binding list itself is well documented [5].

Noribogaine shares much of this target list [7]. The body makes it from ibogaine, and it stays in the blood far longer [1][3]. In Dutch patients, a model fitted to blood samples put the noribogaine peak at about seven and a half hours after the dose [14]. The same model put ibogaine's own peak within about the first hour [14]. Its own half-life runs from 1.6 to 6 hours [1]. Half-life means how long it takes to remove half of a dose.

Ibogaine has no real pull on the alpha-2 receptor, where the standard withdrawal drug clonidine works [4]. The pharmacology article covers each target in more depth.

Does ibogaine work on opioid receptors?

Ibogaine and noribogaine act on opioid receptors without behaving like opioid drugs [3][4]. In healthy volunteers, noribogaine showed no opioid-like effect on pupil size [3]. It showed none on pain tolerance in a cold-water test either [3]. Both tests are sensitive to opioid drugs [3].

Lab work points the same way. In rat brain tissue, ibogaine and noribogaine blocked the mu receptor instead of switching it on [4]. The team concluded that switching on the mu receptor does not appear to explain ibogaine's effect on withdrawal [4]. How this differs from methadone and buprenorphine is covered in Ibogaine vs. Suboxone and Methadone.

The kappa receptor is a different case. In cell studies, noribogaine switches it on in an odd, one-sided way [6].

Picture a receptor with two output wires. Noribogaine sends a strong signal down the first and a weak one down the second [6].

The team suggests the one-sided signal could help explain why noribogaine does not cause low mood [6].

What other brain targets could explain the effect on withdrawal?

Lab work points to three targets outside the opioid system [5][7][18]. One is a glutamate receptor, one is a nicotine-type receptor, and one is the serotonin pump [5][7][18]. Each rates as plausible in the scorecard above.

Picture withdrawal as an alarm wired to several sensors. A drug that reaches several sensors at once could quiet more of the noise.

- The NMDA receptor. It responds to glutamate, a brain chemical. Ibogaine blocks it in lab studies [4][7]. - The alpha3beta4 nicotinic receptor. In human receptors grown in cells, ibogaine plugs the channel [17]. Animal studies tie this more to drug-taking than to withdrawal [4]. - The serotonin pump. In rats, noribogaine raised serotonin in a reward area [18]. It was about ten times as potent as ibogaine at this [18].

Is noribogaine the reason withdrawal relief lasts?

Noribogaine is the leading explanation for why relief outlasts ibogaine itself [1][16]. For most people, ibogaine clears the blood within 14 to 24 hours [1]. The gut wall and liver convert it to noribogaine, using an enzyme called CYP2D6 [1]. The St Kitts researchers judged the lasting after-effects likely to come from noribogaine acting in the brain [1].

Their withdrawal data fit that view. Withdrawal signs stayed mild and none got worse at later checks [1]. The researchers tied this to noribogaine's long half-life [1]. Among people reached a month later, opioid craving was still below its starting level [1].

People's own accounts show how long the relief held. In a survey of former patients, half said their cravings stayed down for at least a week [9]. A quarter said they stayed down for at least three months [9].

Noribogaine stays a long time. In healthy volunteers its half-life ran 28 to 49 hours [3]. In people coming off methadone it ran 24 to 30 hours [15]. A single treatment leaves it in the body for days [1][15].

Think of ibogaine as a match and noribogaine as the slow log it lights. The match flares and goes out within hours. The log keeps burning well into the following days.

The handover runs at a different speed in each person. Genes set how active CYP2D6 is. In Dutch patients, that drove a more than tenfold spread in how fast ibogaine was cleared [14]. In healthy volunteers, blocking CYP2D6 with another medicine roughly doubled exposure to ibogaine and noribogaine combined [19].

Noribogaine is active in people on its own. Given alone to people switching off methadone, it lengthened the heart's QT interval [15]. The rise grew with the dose and with the level in the blood [15]. That is a cardiac risk. In a Dutch study of ibogaine, the QT interval stayed long past the first day in almost half the patients [2].

Animal work supports the noribogaine idea. In mice dependent on morphine, oral noribogaine cut withdrawal signs brought on by an opioid blocker by up to 88 percent [16]. Those authors concluded that noribogaine, rather than ibogaine, blocks this kind of withdrawal [16].

How noribogaine levels rise and fall is covered in Noribogaine: Pharmacokinetics of the Long Tail.

What happens to withdrawal during an ibogaine session?

For most people, withdrawal stays in the background during the session. In a Dutch study, most patients had no withdrawal in the first 24 hours after their dose [14]. In St Kitts, dosing waited until withdrawal had begun, about 12 hours after the last morphine [1].

A vivid, dream-like stage begins between about half an hour and three hours after the dose [1][20]. For most people in St Kitts, it ended abruptly six to eight hours after the dose [1].

A quieter stage follows. People go back over what surfaced, in a mood that is mostly calm and inward [1][20]. Patients in the Dutch study stayed below the threshold for delirium [2]. Sleeplessness often lasts about 72 hours afterwards [20].

The body has its own part in this. Nausea and vomiting are common, and so is unsteady walking [1]. In the Dutch study, all patients lost their balance for a while and could not walk unaided [2].

Cravings shift too. In St Kitts, opioid craving scores were lower by the time people went home [1].

Some mild effects of the drug were still there 24 hours after the dose [1]. They faded soon after [1].

Heart monitoring runs through at least the first day [1][2]. In St Kitts, it started an hour before the dose [1]. More about what these studies found is in Every Major Ibogaine Study, Summarized.

Where the research goes next

Three questions lead the field. The first is how much of the relief noribogaine brings by itself. In its first patient trial, noribogaine alone showed a non-significant trend toward lower withdrawal scores [15]. The trial gave single doses to 27 people coming off methadone [15]. Next, the team planned studies with repeated doses and controlled blood levels [15].

The second is when and where the relief happens in the body. In Dutch patients, how bad withdrawal was did not track the level of either drug in the first 24 hours [14]. The authors suggest the dose sat on a plateau. If so, a lower dose might also hold withdrawal off [14].

In rodents, noribogaine built up in the brain well above blood levels [16]. In other rodent work, almost no noribogaine was left in brain tissue 19 hours after an ibogaine dose [5]. Studies that measure brain levels and withdrawal side by side can settle this.

The third is which target matters most. Engineered relatives of ibogaine can test each idea. In animal studies, 18-MC eased withdrawal as well as ibogaine did, while barely binding the NMDA receptor [4].

Newer oxa-iboga compounds act on the kappa receptor [7]. In human heart cells grown in the lab, they did not upset the beat the way ibogaine does [7]. These programs have their own article, Beyond Ibogaine: Tabernanthalog and Engineered Analogs.

Which of these mechanisms carries over to people is the question controlled human trials are built to answer. Open Questions: What Rigorous Ibogaine Trials Must Answer sets out what those trials need to measure.

Frequently asked questions

Is ibogaine an opioid?

No. Ibogaine is the main alkaloid in the root bark of Tabernanthe iboga, a shrub from Central Africa [2]. In lab tests, ibogaine and noribogaine block the main opioid receptor instead of switching it on [4]. In healthy volunteers, noribogaine showed none of the pupil or pain effects that opioid drugs cause [3].

Does ibogaine help with methadone withdrawal?

In a Dutch hospital study, most patients came from methadone [14]. They moved onto morphine first and then took a single ibogaine dose [2]. Most had no withdrawal in the first 24 hours, and most did not go back to morphine in that time [2][14].

Noribogaine vs. ibogaine: what is the difference?

Noribogaine is the drug the body makes from ibogaine [1]. It lasts much longer in the blood [1][3]. It is the main suspect for why relief outlasts ibogaine [1]. In one Dutch study, unsteadiness during treatment tracked ibogaine levels more closely than noribogaine levels [14].

What is noribogaine's half-life?

Noribogaine's half-life averaged 28 to 49 hours across dose groups in healthy volunteers [3]. In patients on methadone who took it alone, it was 24 to 30 hours [15]. Ibogaine's own half-life is far shorter, at 1.6 to 6 hours [1].

How long do the effects of ibogaine last?

The vivid stage of an ibogaine session lasts about 4 to 8 hours [1][20]. A calmer, reflective stage of roughly 8 to 20 hours follows [20]. Noribogaine stays in the body for days after that [1][15].

Does ibogaine get people high?

People in treatment describe a waking dream full of images and old memories [1][20]. Noribogaine taken alone brought changes in how light looked, with no euphoria [15]. In rats, noribogaine did not create a preference for the place where they received it, a standard sign of a rewarding drug [16].